CVS Health
0
Funds holding %
of 6,814 funds
0
Analysts bullish %
of 9 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
22% more call options, than puts
Call options by funds: $1.79B | Put options by funds: $1.47B
3% more capital invested
Capital invested by funds: $62.8B [Q2] → $64.4B (+$1.64B) [Q3]
0% more funds holding in top 10
Funds holding in top 10: 27 [Q2] → 27 (+0) [Q3]
3.58% less ownership
Funds ownership: 84.54% [Q2] → 80.96% (-3.58%) [Q3]
4% less funds holding
Funds holding: 1,869 [Q2] → 1,796 (-73) [Q3]
23% less first-time investments, than exits
New positions opened: 154 | Existing positions closed: 201
52% less repeat investments, than reductions
Existing positions increased: 477 | Existing positions reduced: 991
Research analyst outlook
9 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$58
21%
upside
Avg. target
$66
37%
upside
High target
$80
67%
upside
9 analyst ratings
8 positive
89%
1 neutral
11%
0 negative
0%
Truist Securities David Macdonald 57% 1-year accuracy 55 / 96 met price target | 25%upside $60 | Buy Maintained | 6 Jan 2025 |
Deutsche Bank George Hill 60% 1-year accuracy 6 / 10 met price target | 37%upside $66 | Buy Upgraded | 3 Dec 2024 |
TD Cowen Charles Ryhee 29% 1-year accuracy 2 / 7 met price target | 67%upside $80 | Buy Maintained | 25 Nov 2024 |
Piper Sandler Jessica Tassan 29% 1-year accuracy 6 / 21 met price target | 33%upside $64 | Overweight Maintained | 25 Nov 2024 |
Wells Fargo Stephen Baxter 24% 1-year accuracy 9 / 38 met price target | 37%upside $66 | Overweight Upgraded | 18 Nov 2024 |
Financial journalist opinion
Based on 33 articles about CVS published over the past 30 days
Positive
The Motley Fool
12 hours ago
3 High-Yield Dividend Stocks Wall Street Thinks Will Soar 41% or More in 2025
How would you like to get paid to sit back and watch a stock you own take off? That's a scenario most investors would love.
Neutral
PRNewsWire
1 day ago
CVS Health supporting customers, patients, members and colleagues amid California wildfires
WOONSOCKET, R.I. , Jan. 10, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) is actively supporting its customers, members, provider partners and colleagues as they respond to the California wildfires.
Positive
Seeking Alpha
2 days ago
CVS Health: An Attractive 5.8% Safe Yield For Now
Despite significant headwinds and a 43% stock decline, CVS Health's 5.8% dividend yield remains attractive, with a well-covered payout ratio of 55.9%. CVS faces strong competition from Amazon, Walmart, and Costco, impacting market share and pushing management to revise cash flow guidance down to $9.0 billion. The company saw double-digit revenue growth in two of its three segments, with a slight increase in pharmacy market share to 27.3%.
Negative
The Motley Fool
3 days ago
After Falling More Than 40% in 2024, Can CVS Health Stock Turn Things Around This Year?
CVS Health (CVS 0.50%) is a stock that's been struggling badly for multiple years and is coming off a brutal performance in 2024, when its shares nose-dived by 43%.
Positive
Zacks Investment Research
5 days ago
Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Positive
Forbes
6 days ago
This Stock Has A 5.81% Yield And Sells For Less Than Book
CVS Health has been named as a Top 25 dividend stock, according the most recent Dividend Channel ''DividendRank'' report. The report noted that among the coverage universe, CVS shares displayed both attractive valuation metrics and strong profitability metrics.
Negative
Zacks Investment Research
6 days ago
CVS Stock Trades Near 52-Week Low: Should You Buy the Dip?
CVS Health's Medicaid business is experiencing medical cost pressure from higher-than-expected acuity following the resumption of member redeterminations.
Neutral
PRNewsWire
6 days ago
CVS Pharmacy achieves CVS CostVantage milestone
All commercial prescriptions dispensed at CVS Pharmacy will be reimbursed through CVS CostVantage starting this year Innovative approach uses a transparent formula built on the drug acquisition cost, a set markup, and a fee to reflect the quality of pharmacy services provided New reimbursement model supports future of retail pharmacy and paves the way for improved PBM transparency WOONSOCKET, R.I., Jan. 6, 2025 /PRNewswire/ -- Delivering on the promise of a simpler, more transparent, and more sustainable approach to retail pharmacy services, CVS Health® (NYSE: CVS) today announced that all of the commercial prescriptions dispensed through CVS Pharmacy® are contracted through the company's innovative CVS CostVantage reimbursement model starting this year.
Neutral
PRNewsWire
1 week ago
CVS Health announces quarterly dividend
WOONSOCKET, R.I. , Jan. 3, 2025 /PRNewswire/ -- CVS Health (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation.
Positive
Benzinga
1 week ago
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Charts implemented using Lightweight Charts™